Lizhu Lin

机构：Heilongjiang Academy of Land Reclamation Sciences · ORCID：0000-0002-5651-5252

发表论文 6 篇 · 总被引 271 次 · h-index 4

代表论文

• Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309) (2023 · Cancer Cell · 被引 226)
• Effect of Chinese Herbal Medicine on the Survival of Colorectal Cancer Patients With Liver-Limited Metastases: A Retrospective Cohort Study, 2008 to 2017 (2019 · Integrative Cancer Therapies · 被引 17)
• A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer. (2015 · Journal of Clinical Oncology · 被引 16)
• 912MO A single-arm, open-label, multicenter phase II study of camrelizumab in patients with recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) who had progressed on ≥2 lines of chemotherapy: CAPTAIN study (2020 · Annals of Oncology · 被引 7)
• Clinical Efficacy of Hexue Tongbi Formula on Oxaliplatin-Induced Peripheral Neuropathy: A Randomized Controlled Study (2024 · Integrative Cancer Therapies · 被引 1)
• Predictive models of lymph node metastasis in patients with gastrointestinal stromal tumors based on machine learning algorithms: a SEER-based retrospective study (2025 · Journal of Gastrointestinal Oncology)